EUROPEAN OPHTHALMIC REVIEW – VOLUME 13 – ISSUE 1 – SUMMER 2019

The past decade has seen a number of important advances in the management and understanding of corneal disease. Corneal cross-linking (CXL) is a technique that combines ultraviolet (UV) light and the chromophore, riboflavin, to stiffen and strengthen the cornea. The introduction of CXL has transformed the management of corneal ectasias such as keratoconus, post-LASIK ectasia […]

Corneal refractive surgery is a common choice for reducing the dependence of vision correction by glasses or contact lenses. However, as with any form of surgery or medical treatments, there is an inherent risk of complications. These risks, and their subsequent management, can vary widely depending on which technique is employed and the preoperative assessment.1,2 In […]

Dry eye disease (DED) is a common ocular condition with a high impact on visual function and quality of life.1 However, DED is one of the most misdiagnosed diseases because of a delay in symptoms and clinical signs, and the lack of unitary diagnostic criteria.2,3 Moreover, current diagnostic tests are useful only in severe cases.2 […]

The PRESERFLO™MicroShunt (Santen, Osaka, Japan), formerly known as the InnFocus MicroShunt (Santen, Osaka, Japan), is a minimally invasive glaucoma drainage device, intended to shunt aqueous humour from the anterior chamber (AC) of the eye to a filtration bleb, formed under the conjunctiva and Tenon’s capsule. The device was initially designed for use in patients with […]

Over the past two decades, new innovations have led to a dramatic increase in the number of microsurgeries performed in many surgical specialties. However, microsurgery using the traditional binocular microscope can lead surgeons to deleterious neck and back postures that cause musculoskeletal fatigue and injuries, which has been associated with reduced surgical longevity.1 The prevalence […]

Various options for the prevention of pseudophakic cystoid macular oedema (PCMO) have been offered. Nonsteroidal anti-inflammatory drugs (NSAIDs) seem to be beneficial in preventing postoperative inflammation; however, there is lack of evidence for long-term benefit after cataract surgery. What is more, topical NSAID preparations are difficult to compare, as studies differ in inclusion criteria, patient […]

Diabetic macular oedema (DMO) is a complication of diabetic retinopathy and is a leading cause of blindness in working-age adults in developed nations. In 2015, there were an estimated 415 million people with diabetes worldwide.1 This number is predicted to rise to 642 million by 2040.1 The prevalence of DMO is estimated to be up […]